Lantern Pharma Inc.
NASDAQ:LTRN

Watchlist Manager
Lantern Pharma Inc. Logo
Lantern Pharma Inc.
NASDAQ:LTRN
Watchlist
Price: 3.6 USD -3.74% Market Closed
Market Cap: 40.2m USD

Wall Street
Price Targets

LTRN Price Targets Summary
Lantern Pharma Inc.

Wall Street analysts forecast LTRN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for LTRN is 20.4 USD with a low forecast of 15.15 USD and a high forecast of 26.25 USD.

Lowest
Price Target
15.15 USD
321% Upside
Average
Price Target
20.4 USD
467% Upside
Highest
Price Target
26.25 USD
629% Upside
Lantern Pharma Inc. Competitors:
Price Targets
SPRB
Spruce Biosciences Inc
156% Upside
DVYSR
Devyser Diagnostics AB
41% Upside
XGN
Exagen Inc
121% Upside
GLTO
Galecto Inc
2% Upside
688266
Suzhou Zelgen Biopharmaceuticals Co Ltd
48% Upside
AMGN
Amgen Inc
3% Upside
ALXO
ALX Oncology Holdings Inc
108% Upside
ALEC
Alector Inc
43% Upside

Revenue
Forecast

Revenue Estimate
Lantern Pharma Inc.

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Lantern Pharma Inc.

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-4%
Average Miss

Net Income
Forecast

Net Income Estimate
Lantern Pharma Inc.

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-11%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is LTRN's stock price target?
Price Target
20.4 USD

According to Wall Street analysts, the average 1-year price target for LTRN is 20.4 USD with a low forecast of 15.15 USD and a high forecast of 26.25 USD.

Back to Top